Medical News

RSS

Sperm freezing for young male cancer patients

A recent study at Hamilton Health Sciences proves that sperm freezing and banking is an effective way to preserve fertility in adolescents and young adult (AYA) males with cancer.

23 Jul 2007

Nicotine rush hinges on sugar in neurons

As with other questions involving good sensations, the answer appears to be sugar.

23 Jul 2007

New hope for common form of childhood cancer

Dr. Richard Lock, Head of the Leukaemia Biology Program at the Children's Cancer Institute Australia for Medical Research, Sydney, along with collaborators from the Childrens Hospital Los Angeles and University of Southern California, USA, recently published their findings in the prestigious scientific journal Blood.

23 Jul 2007

Medical students respond positively to simulated patient experience

When a vomiting, simulated patient mannequin was rolled into the lecture hall last fall to teach large numbers of first- and second-year Wake Forest University School of Medicine students about the brain and nervous system, Michael T. Fitch, M.D., Ph.D., wasn't sure what to expect.

23 Jul 2007

Latest drugs improve survival for metastatic breast cancer

Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.

23 Jul 2007

Koronis Pharmaceuticals issued U.S. patent for KP-1461 therapeutic in development for treatment of HIV

Koronis Pharmaceuticals, Inc. has announced the issuance of U.S. Patent No. 7,244,732 that discloses the composition of KP-1461 -- the Company's lead antiviral therapeutic currently in a Phase 2 trial for the treatment of human immunodeficiency virus (HIV) infection.

23 Jul 2007

Research to look at reasons for the formation of Lewy bodies

A University of Nottingham researcher has been awarded more than £440,000 by the Parkinson’s Disease Society (PDS) to investigate the causes of the condition.

23 Jul 2007

IDM Pharma plans to amend NDA for Mifamurtide (L-MTP-PE) for the treatment of osteosarcoma

IDM Pharma, Inc. has announced that it has recently met with the U.S. Food and Drug Administration (FDA) and informed the FDA that the Company intends to take immediate action to supplement the data in its current New Drug Application (NDA) for mifamurtide (L-MTP-PE), formerly known as Junovan, which is being reviewed for the treatment of children and adolescents with non-metastatic osteosarcoma.

23 Jul 2007

Urgent needs of HIV-positive women discussed

Women Living Positive, a roundtable discussion at the IAS congress in Sydney, featured the perspectives of an international panel, including experts in HIV research and medicine, an HIV-positive woman and a member of Australia's National Association of People Living with HIV/AIDS (NAPWA), on the progress that has been made, and what remains to be done to address the needs of HIV-positive women.

23 Jul 2007

Health-care providers could help avert depression in fathers of children with fatal cancer

Adequately preparing parents, intellectually and emotionally, for the death of their child is associated with parents’ future health, according to an Article published Online this week and in The Lancet Oncology special edition on paediatric oncology.

23 Jul 2007

How do newcomers make changes in long-standing groups?

Virtually everyone who joins a new group is sensitive to the fact that, as a newcomer, he or she must tread carefully for a while, keeping a low profile until becoming sufficiently integrated into the group.

23 Jul 2007

Group therapy does not prolong the lives of women with metastatic breast cancer

Earlier results from the same researcher had suggested a survival benefit of group therapy for women with metastatic breast cancer. However, the new study did find that women with estrogen receptor (ER) negative tumors did show survival benefit, and that group therapy improved quality of life (QOL).

23 Jul 2007

EpiCept to conduct Phase III study of EpiCept NP-1 for treatment of chemotherapy induced peripheral neuropathy

EpiCept Corporation has announced that it will study EpiCept NP-1, its patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine, for the treatment of chemotherapy induced peripheral neuropathy (CPN) in the ATTRACT-CPN Phase III Study (Assessment of Topical Treatment Response with Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy).

23 Jul 2007

Patients' perspectives on living with HIV

Recent launches of new protease inhibitors and the anticipated availability of new antiretroviral drug classes have increased the therapeutic options available to treatment-experienced HIV-positive patients, and made achieving an undetectable viral load a realistic goal for this patient population.

23 Jul 2007

Nanotechnology to test food quality

Researchers have created two tiny instruments capable of detecting a range of contaminants, from molecules to whole bacteria, in food and water, according to an article in the August issue of Microbiology Today.

23 Jul 2007

Court dismisses Gen-Probe court action against Digene

Digene Corp. has announced that a California state court has dismissed a complaint filed against the company by Gen-Probe, Inc., without option to amend. Gen-Probe's complaint asked the court to declare that an agreement between Gen-Probe and F. Hoffman-LaRoche Ltd.

23 Jul 2007

Chemotherapy beneficial for children with intracranial ependymoma

Use of chemotherapy to treat children with intracranial ependymoma avoids or delays the need for use of radiotherapy which can potentially cause serious damage to the child's nervous system, without compromising chances of survival.

23 Jul 2007

Chemo instead of radiotherapy cuts long-term side effects for children with brain tumours

Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.

23 Jul 2007

Study looks at cancer incidence among recipients of blood from donors

Individuals who receive blood transfusions from donors with undiagnosed cancers are at no higher risk of developing malignant disease than people who receive blood from donors without cancer, according to the results of a retrospective study published in The Lancet last month.

23 Jul 2007